2-Day Seminar: U.S. Patent Practice (London, United Kingdom – June 13-14, 2019) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “US
Patent Practice”
conference has been added to ResearchAndMarkets.com’s
offering.

US Patent Practice, What European patent attorneys need to know. A
2-day highly interactive seminar.

Key Topics Covered

  • Legal framework
  • AIA overview
  • US patent prosecution
  • Enablement
  • Definiteness
  • Novelty and prior art
  • Obviousness
  • Provisional and continuing applications in USPTO programs
  • Duty of candor
  • Infringement
  • Patent litigation and damages

Why You Should Attend

The area of US patent practice can be complex and confusing. Are you up
to date with the latest court decisions and best practice?

This highly interactive seminar will give you a comprehensive
understanding of the US patent system and enable you to work more
effectively with your US counterparts. It highlights the important
differences between US and European patent practice and gives you the
opportunity for in-depth discussions about prosecution practice and
procedure throughout the two days. It includes important tactics to get
the most out of your prosecution dollar, and provides lots of claim
drafting tips to give your application a solid footing for US
prosecution and enforcement.

This seminar will bring you right up to date on the latest legislative
changes under the America Invents Act (AIA), as well as all the recent
and pending US Supreme and other court decisions of importance. Plus,
get to grips with the current happenings in the USPTO that could impact
on your role.

This is a fantastic opportunity to take full advantage of the open
seminar environment that this event offers. With a high degree of
interaction with the expert seminar faculty as well as other
participants, this is a great forum for discussing your particular
questions and concerns. Offering a wide-ranging and detailed
understanding, this seminar covers what every European patent
practitioner should know about US patent practice.

Accreditation

This seminar merits 12.5 hours under the UK Solicitors Regulatory
Authority self accreditation scheme (refg. CJA/MAFO) and may also be
relevant training under the IPREG CPD self accreditation scheme.

Continuing professional development

This course qualifies for the following CPD programmes:

  • CPD certificate of attendance: 5.50 hours
  • General Council of the Bar: 5.50 hours

Who Should Attend

  • Corporate Patent Counsel
  • Patent Attorneys from corporate and private practice
  • Intellectual Property Consultants
  • Patent Managers and Engineers
  • Company Legal Advisers
  • All those involved with patent protection in the United States

Agenda

Programme day one

Legal framework

  • Statutes and rules
  • Courts and agencies
  • Requirements for patentability

Claim construction

  • Phillips – broad multifaceted inquiry
  • Claim construction rules and guidelines
  • Claim construction in the USPTO

US patent prosecution – general flow of events

Written description

  • Possession’ of claimed invention
  • Ariad – increased focus on what inventors actually did
  • Written description guidelines
  • Negative limitations

Enablement

  • Wands factors – to show whether the amount of experimentation
    necessary would be undue’
  • Interplay with written description requirement

Best mode

  • Effect of the AIA

Definiteness

  • Nautilus – the reasonable certainty’ standard
  • USPTO practice

Means-plus-function claiming

Statutory subject matter

  • Supreme Court jurisprudence
  • USPTO guidance
  • Court of Appeal

Utility

  • Impossibility
  • Judicial interpretation

Patent Law Treaty implementation

Novelty and prior art

  • Anticipation
  • Pre-AIA – first to invent’
  • Post-AIA – first to file’

Programme day two

Novelty/prior art (if necessary)

Obviousness

  • Graham and KSR
  • USPTO practice – prima facie obviousness
  • USPTO KSR guidelines
  • Method claims

Provisional applications

  • Pre-AIA vs post-AIA

Continuing applications

  • Continuations, divisionals, continuations-in-part

Restriction practice

  • Restriction requirement
  • Restriction vs Election of Species
  • Rejoinder

Patent term and PTA

Obviousness – type double patenting

  • Gilead cases
  • Terminal disclaimers

USPTO programs

  • Terminal disclaimers

Patent Law Treaty implementation

Obviousness – type double patenting (continued)

  • Accelerated examination, track one, patent prosecution highway
  • First action interview, after-final consideration, pre-appeal brief
    request for review pilot programs

Duty of candor

  • Citation of references
  • Inequitable conduct

Inventorship

  • Conception
  • Joint inventorship
  • Interference practice
  • Derivation actions

Post-issuance practice

  • Re-examination and re-issue
  • Inter parties review
  • Post-grant review
  • Covered business method review
  • Supplemental examination
  • Certificates of correction

Infringement

  • Direct infringement
  • Contributory infringement and inducement
  • Extraterritorial infringement
  • Exhaustion

Doctrine of equivalents

  • Function/way/result test
  • Festo – prosecution history estoppel
  • Licensing

Willfulness

  • Opinions

Declaratory judgment

  • Burdens of proof

Patent litigation and damages

  • Remedies
  • Entire market value
  • Injunctive relief

For more information about this conference visit https://www.researchandmarkets.com/r/ojmu8p

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Patents

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

For the last half century, thousands of communications professionals have turned to us to deliver their news to the audiences most important to their business through the sources they trust most. Over that time, we've gone from a single office with one full time employee to more than 500 employees in 32 bureaus.